Analysis

Tevogen Bio Holdings Inc. (TVGN) Stock Analysis

Tevogen Bio Holdings Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to TVGN.

websiteTVGN/analysis/TVGN

Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to TVGN.

Stock profile

Ticker

TVGN

Asset type

Stock

Market cap

$39.9M

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Tevogen Bio Holdings Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • TVGN primary listing
  • G280

Latest Tevogen Bio Holdings Inc. news

Tevogen Announces Formation of a Healthcare Services Initiative

William Keane Appointed Interim Head of Initiative, Evaluating Potential Management Services Organization and Contract Research Organization Acquisitions WARREN, N.J., June 09, ...

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue

Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue Tevogen Advances Strategic Acquisition Initiat...

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization

Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Mana...

Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close

WARREN, N.J., May 12, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that it has entered into a securities purchase a...

Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal

WARREN, N.J., April 27, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced continued progress within its artificial intel...

Research sections

Valuation

Review valuation context for Tevogen Bio Holdings Inc..

Future growth

Review future growth context for Tevogen Bio Holdings Inc..

Past performance

Review past performance context for Tevogen Bio Holdings Inc..

Financial health

Review financial health context for Tevogen Bio Holdings Inc..

Dividend

Review dividend context for Tevogen Bio Holdings Inc..

Management

Review management context for Tevogen Bio Holdings Inc..

Ownership

Review ownership context for Tevogen Bio Holdings Inc..

Other information

Review other information context for Tevogen Bio Holdings Inc..

Community

Review community context for Tevogen Bio Holdings Inc..